New cancer drug enters first human safety tests
Disease control
Not yet recruiting
This is an early safety study for a new drug called BSI-082, designed for adults with advanced solid tumors that have spread or stopped responding to standard treatments. The study has two parts: first testing BSI-082 alone at increasing doses, then testing it combined with anoth…
Phase: PHASE1 • Sponsor: Lei Zheng • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC